Share Name Share Symbol Market Type Share ISIN Share Description
Surgical Innov. LSE:SUN London Ordinary Share GB0004016704 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 2.90p 2.80p 3.00p 2.90p 2.90p 2.90p 620,155 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 8.8 0.5 0.1 29.0 22.69

Surgical Innovations Share Discussion Threads

Showing 10526 to 10549 of 10550 messages
Chat Pages: 422  421  420  419  418  417  416  415  414  413  412  411  Older
DateSubjectAuthorDiscuss
28/6/2018
14:52
Must be some overhang here as lots of buying over the last 2 days in reasonable chunks but yet the price stays flat, humm games at play
bashor
27/6/2018
09:00
It would be good to see some directors putting their hard earned to play and increasing holdings, maybe we will see something given yesterday’s volume
bashor
26/6/2018
10:12
Not bad ''Management have used this period of subdued demand to bear down further on working capital, delivering significant reductions in inventory levels and strong cash flow. The Group is expected to have little or no net debt at 30 June 2018.'' Anyone that has managed to buy recently at under 3p , could have bought at a low for the share for this year. Provided that the following comes to pass ''we anticipate much stronger results in the second half of the year.'' '' We anticipate further opportunities to improve our market share across several key geographical markets to be delivered in the coming months.'' ''Revenues from OEM customers have been steady, and are expected to increase in the second half of the year'' And provided that investors are informed by RNS of any positive developments as they occur Should keep those who took part in the 3p placing on board and reasonably happy 26 June 2018 Surgical Innovations Group plc ("SI", "the Company" or the "Group") AGM Statement Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery, holds its Annual General Meeting at 3pm today. At the meeting, Executive Chairman, Nigel Rogers, will make the following statement: Total group revenues for the six months ending 30 June 2018 are expected to exceed £5m with gross margin and profitability slightly ahead of the corresponding period last year. For the reasons indicated below, we anticipate much stronger results in the second half of the year. Export sales of SI branded products are gaining increasing traction in many overseas markets, as a result of product range extensions, additional sales resources and business development initiatives. We anticipate further opportunities to improve our market share across several key geographical markets to be delivered in the coming months. Market conditions in the UK during the first half of the year have been challenging as a result of reduced activity levels of elective surgery in the NHS, and the supply chain disruption in respect of the Cellis range of biological matrices. There are positive signs that NHS hospitals are continuing to return to normalised activity levels, and recent government policy announcements regarding a longer-term funding settlement for the NHS are encouraging. Distribution sales in the UK market will also benefit from additional product lines taken on during the first half of the year, and the renewal of a number of key contracts. Revenues from OEM customers have been steady, and are expected to increase in the second half of the year, following the redesign of certain key products and additional revenues from precision engineering products. Management have used this period of subdued demand to bear down further on working capital, delivering significant reductions in inventory levels and strong cash flow. The Group is expected to have little or no net debt at 30 June 2018. Interim results for the first half of the year will be released in September 2018.
buywell3
26/6/2018
09:48
Biggest burden on the share price is the Number of Cheap/Free shares that were soaked up, on a regular basis, by Company directors!
gbh2
26/6/2018
08:04
Debt free soon
jmf69
26/6/2018
08:03
Positive that good growth will come here
bashor
26/6/2018
07:59
Anyone going to the AGM today?
jmf69
26/6/2018
07:52
Update seems reasonable given the warning issued last month.
jmf69
22/6/2018
20:56
Forecasts are for 0.16 from WHI...
pireric
22/6/2018
17:06
Added 2.85p. AGM Tuesday and hopefully a better update. Management need to deliver here. Full year EPS needs to be hitting 0.3-0.4p
justiceforthemany
21/6/2018
14:35
Added at 2.8p
bashor
21/6/2018
09:25
You know our directors are senior members of the Senior Wrist Club Operators and then their sins will be forgiven by The Vatican Truth Directorate. As ever regards VZ
van zandt
20/6/2018
16:17
Gbh2, this is hard to watch but I take comfort in the fact that the pound is weak against the dollar and that ought to help with any US earnings, given they are going to make more profit than last year even with the drop in revenue I’d say these are an add at this level
bashor
20/6/2018
12:34
Must be approaching time for yet another load of shares to be dumped on the market?
gbh2
13/6/2018
11:51
VZ - are we supposed to be grateful for your latest dose of innuendo and supposition? We're all grown ups here and quite capable of forming our own opinions on the current situation with SUN. As ever, regards etc etc.
lurki0
12/6/2018
11:41
Glad to see the Walbrook/The Vatican getting in on the act, how extraordinary that they Walbrook /The Vatican// should post a link to a two page utterly useless summery. So the question is why they would do that and how many other BB’s sites have they posted it on? We should be told. For example does anyone seriously think that a small French company with a tiny turnover could/would be responsible for a major profit impairment warning from SUN? Grow-up. So it can be very reliably said that anyone topping up or a substantial holding should look no further than what is going on in and around the Board Room right now. As ever regards VZ
van zandt
07/6/2018
17:02
Walbrook thanks for that, I have a substantial holding so do hope the next couple of years turn around as expected without anymore warnings, I have faith in the current board to turn this into a better more profitable company and restore shareholder value
bashor
07/6/2018
15:20
This post is from Walbrook PR, and we provide financial PR and IR services for Surgical Innovations. Please follow the link to download a free two page investment summary on Surgical Innovations: https://tinyurl.com/y8mzhavp
walbrook2
31/5/2018
15:47
Managed to top up this morning at just under 3p
jmf69
31/5/2018
13:10
Re RNS Key sentence for me 'With the assumption of reduced revenues, the Board anticipates that profit before tax will show modest growth over that reported for the financial year ended 31 December 2017.' However The RNS looks at a worst case scenario of NO Cellis product sales in the current year. Which means there might be a chance of SOME sales if Cellis/SUN sort things out ASAP ie quicker IMO a moderate growth would be around 10% At 3p , SUN has presented a chance for some to buy in at the last cash raising price Many here moaned about being excluded. ''The SI Board has determined that it would be prudent to exclude revenues from Cellis products from current year expectations until such time as there is certainty regarding the availability of current and new products in this range following regulatory approval. This has the effect of reducing revenue expectations for the current financial year by approximately 10%, or GBP1.25m, on the cautious assumption that sales do not resume in the current year. Revenues from other segments of SI Group activities, comprising the worldwide sale of SI brand products manufactured in the UK and the design and manufacture of OEM products, are unaffected. With the assumption of reduced revenues, the Board anticipates that profit before tax will show modest growth over that reported for the financial year ended 31 December 2017. Further market updates will be provided as this situation develops, and a further trading update will be presented on the day of the Annual General Meeting which will be held at 3.00 p.m. on 26 June 2018 at WH Ireland Limited, 24 Martin Lane, London EC4R 0DR.'' Over 5M shares traded today so far Around 19M shares traded in last 4 trading days including this Seems IMO that the drop was a tad overdone Positive news soon could push this back to 3.75p to 4p quite rapidly dyor
buywell3
31/5/2018
10:09
Nice to see a little interest and higher volume today
bashor
30/5/2018
10:04
Just bought some more at 2.9p
bashor
29/5/2018
17:19
Hi, you should be able to glean all you need from the following: hxxp://www.medicaldevices24.com/lists/producers/meccellis-biotech/11090 hxxps://lk.kompass.com/c/meccellis-biotech/fr0935223/ hxxps://clinicaltrials.gov/ct2/show/NCT02831426 https://www.youtube.com/watch?v=IxJNJP1Y8z4 hxxp://www.microlinesurgical.com/customer-service/microline-bv hxxp://www.microlinesurgical.com/company/about-microline-surgical hxxps://www.businesswire.com/news/home/20090424005009/en/Company-Profile-Microline-Surgical As ever regards, VZ
van zandt
29/5/2018
16:50
It’s a buy again for me at this level
bashor
Chat Pages: 422  421  420  419  418  417  416  415  414  413  412  411  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20180716 12:13:34